Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycerol adjuvant therapy in adult bacterial meningitis in Malawi
ISRCTN70121840Phase 2Terminated
- Sponsor
- Kamuzu University of Health Sciences
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of glycerol in bacterial meningitis (5 arms), sponsored by Kamuzu University of Health Sciences. Primary endpoints: Tolerability of glycerol adjuvant therapy, Serious adverse events and 1 more. Started Jan 2006; status: terminated.
02
Drugs
glycerol
03
Conditions
bacterial meningitis
Beyond the preview
Go deeper on ISRCTN70121840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70121840.